Diversified Consumer Services
Company Overview of University of Cambridge
University of Cambridge is a public university that offers graduate, postgraduate, and research programs in the field of science, business, social sciences, and law. It offers courses in history, environmental studies, psychology, sociology, zoology, oriental studies, business administration, philosophy, biochemistry, music, engineering, geology, architecture, international relations, and medicine. The institution was founded in 1209 and is based in Cambridge, United Kingdom.
The Old Schools
Cambridge, CB2 1TN
Founded in 1209
Key Executives for University of Cambridge
Regius Professor of Physic
Master of Pembroke College
Head of Institute for Stem Cell Biology
Compensation as of Fiscal Year 2016.
University of Cambridge Key Developments
University of Cambridge Presents at Family Office & Private Wealth Management Forum 2016, Jul-19-2016 02:30 PM
Jun 14 16
University of Cambridge Presents at Family Office & Private Wealth Management Forum 2016, Jul-19-2016 02:30 PM. Venue: Hyatt Regency Newport, Newport, Rhode Island, United States. Speakers: Richard Swart, Alternative Finance-Research Advisor.
Trimble Partners with the University of Cambridge to Collaborate on Research in Engineering and Construction Technology
Apr 20 16
Trimble announced that it is partnering with the University of Cambridge to collaborate on research to advance technology development in the engineering and construction industry. Trimble will work closely with the Laing O'Rourke Centre's Construction Information Technology Laboratory (CIT). CIT is a research facility with a mission to solve complex engineering problems and automate difficult construction tasks through decision support tools. These tools would recognize data patterns, retrieve useful information and generate knowledge of the built environment. The construction industry is highly information-intensive and requires extensive data and information exchange during the construction process between project stakeholders. To enhance competitiveness and efficiency, engineering and construction companies are adopting new forms of information technology to improve productivity, scheduling, quality and costs of a project. The goal of the Trimble sponsorship program is to enable research focused on advanced, accessible and intuitive technologies that can drive increased collaboration for the Design-Build-Operate (DBO) lifecycle of buildings and infrastructure. The Trimble sponsorship program will support cutting-edge research in construction information technology. The initial focus of the collaboration is to enable world-class academic research that has the potential to achieve a significant impact across the construction industry to improve safety, reduce costs, and increase predictability and operational efficiency; provide educational and professional development to encourage and champion construction information technology research in academia and industry; and focus on accelerating the advantages of Building Information Modeling (BIM) in construction as well as the use of computer vision and augmented reality technologies to simplify a wide variety of common construction problems in practical applications.
AstraZeneca, GlaxoSmithKline, Johnson & Johnson and Imperial College London, University of Cambridge and University College London Join For U.K. Drug Development Fund
Jan 27 16
AstraZeneca, GlaxoSmithKline, Johnson & Johnson and three U.K. universities 'Imperial College London, University of Cambridge and University College London (UCL)' are combining to create an almost-$60 million investment fund for drug development. The program, the Apollo Therapeutics Fund, aims to accelerate the translation of academic science into medicines. The partners plan to develop drugs for all therapy areas using systems including small molecules, peptides, proteins, antibodies, and cell and gene therapies. The industrial partners will contribute close to $15 million apiece to the fund over six years. The university partners will each contribute a further $5 million. It is the first time global drug companies and major universities have joined for such a fund, the partners say. Apollo will hire ex-industry scientists to create a drug discovery team that will work with the universities and their technology transfer offices to identify and shape projects. Preclinical research will be advanced to a stage at which it can either be taken forward by one of the industrial partners following an internal bidding process or out-licensed. For projects that become a commercial success, the originating university and its technology transfer office will receive a percentage of commercial revenues or out-licensing fees. The remainder of the income will be divided among the other Apollo partners. By combining funding for promising early-stage therapeutics from the universities with industry expertise, Apollo aims to cut costs and the risk of project failure and accelerate the development of new treatments.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|